Marcus Conrad Selected Research

Subcutaneous Injections

12/2020

Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus Conrad Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 08/2009
7	Reperfusion Injury 03/2024 - 12/2011
4	Ischemia 11/2021 - 12/2011
3	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2021
3	Neuroblastoma 01/2024 - 01/2018
3	Hypoxia (Hypoxemia) 10/2023 - 12/2011
3	Atrophy 11/2021 - 05/2014
3	Necrosis 01/2021 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2008
3	Inflammation (Inflammations) 10/2019 - 08/2011
2	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2020
2	Disease Progression 04/2022 - 10/2017
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2014
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2014
2	Starvation 10/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 12/2020 - 11/2016
2	Carcinogenesis 01/2018 - 11/2010
2	Seizures (Absence Seizure) 01/2018 - 03/2010
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2011 - 05/2011
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2024
1	Rupture 10/2023
1	Cysts 07/2023
1	Glomerulonephritis 01/2023
1	Lupus Nephritis 01/2023
1	Cognitive Dysfunction 04/2022
1	Hypersensitivity (Allergy) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Sedaghatian type Spondylometaphyseal dysplasia 01/2022
1	Poisoning 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Strudwick syndrome 11/2021
1	Perinatal Death 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Colitis 01/2021

Drug/Important Bio-Agent (IBA)

15	IronIBA 04/2024 - 03/2017
10	Glutathione (Reduced Glutathione)IBA 07/2023 - 11/2010
10	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 07/2023 - 09/2009
6	EnzymesIBA 01/2023 - 11/2010
5	LipidsIBA 01/2024 - 12/2014
4	Selenoproteins (Selenoprotein)IBA 11/2021 - 03/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 11/2010
4	Cystine (L-Cystine)IBA 01/2021 - 04/2011
4	Glutamic Acid (Glutamate)FDA Link 01/2021 - 04/2011
4	ThioredoxinsIBA 04/2015 - 03/2008
4	Thioredoxin-Disulfide ReductaseIBA 04/2015 - 03/2008
3	SeleniumIBA 11/2021 - 03/2010
3	Cysteine (L-Cysteine)FDA Link 10/2021 - 06/2014
3	AntiportersIBA 01/2021 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
3	AntioxidantsIBA 10/2017 - 11/2010
3	Vitamin E FDA LinkGeneric 07/2015 - 08/2013
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2023 - 04/2015
2	Vitamin K FDA Link 07/2023 - 01/2022
2	NAD (NADH)IBA 07/2023 - 01/2020
2	SelenocysteineIBA 01/2023 - 01/2018
2	selenium transferaseIBA 11/2021 - 05/2014
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2021 - 11/2019
2	erastinIBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2018
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2017 - 03/2010
1	Interleukin-2 (IL2)IBA 04/2024
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 03/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2024
1	7-dehydrocholesterolIBA 01/2024
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2023
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 10/2023
1	ElementsIBA 10/2023
1	UbiquinoneIBA 07/2023
1	Selenoprotein PIBA 01/2023
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 04/2022
1	ApolipoproteinsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	human PRMT2 proteinIBA 01/2022
1	CalciumIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	liproxstatin-1IBA 01/2022
1	selenocysteinyl-tRNAIBA 11/2021
1	MTOR InhibitorsIBA 10/2021
1	torinIBA 10/2021
1	BODIPY581IBA 10/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	tung oilIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Verteporfin (Visudyne)FDA Link 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021

Therapy/Procedure

12	Therapeutics 07/2023 - 11/2016
1	Immunotherapy 04/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024
1	Oral Administration 01/2021